NORTH is dedicated to accelerating breakthroughs at the intersection of biology and agriculture. As a boutique venture capital enterprise headquartered in Luxembourg, it partners with visionary scientists and entrepreneurs to build companies that address major human and planetary health challenges. NORTH’s mission aligns with the goal of establishing a cutting edge innovation ecosystem: it backs transformative ventures in medical, agricultural and industrial biotechnology. By investing in companies developing advanced crop science, smart farming systems and next generation therapeutics, NORTH helps bring innovations to market that improve crop yields, reduce resource consumption and enhance global food security.
Beyond capital, NORTH provides entrepreneurs with strategic guidance and mentoring. It aims to offer innovative solutions and align interests for mutual success, striving to support founders with the financial resources and support they need to inspire tremendous growth.
The firm is committed to generating superior returns while making a positive impact on people’s lives and the planet. Its process driven approach encourages audacious goals and fosters exceptional accomplishments.
NORTH’s image is one of agility, expertise and integrity. The firm curates a focused portfolio, enabling deep engagement with each company. It is recognised for transparency and fairness, offering unorthodox solutions to de risk investments and nurture success. Situated in Luxembourg’s stable and internationally connected environment, NORTH leverages global partnerships to drive innovation and foster a sustainable biotech and agri tech ecosystem. By blending scientific insight with entrepreneurial spirit, NORTH positions itself as a catalyst for enduring value – championing technologies that nourish both humanity and the earth.
